Most cited papers from Jenner Institute

Jenner Institute

What are the most cited papers from Jenner Institute?

The most cited paper from Jenner Institute is "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK" (Merryn Voysey et al., 2020), with 5,030 citations. Next come "VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines" (3,092) and "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial" (2,629).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 365 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey et al. · The Lancet Open access765 authors	8 Dec 2020	5,030
2	VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines Irini Atanas Doytchinova, Darren R. Flower · BMC Bioinformatics Open access	5 Jan 2007	3,092
3	Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Pedro M. Folegatti et al. · The Lancet Open access365 authors	20 Jul 2020	2,629
4	Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial Maheshi N Ramasamy et al. · The Lancet Open access421 authors	19 Nov 2020	1,415
5	Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant Shabir Ahmed Madhi et al. · New England Journal of Medicine Open access	16 Mar 2021	1,322
6	Targeting bromodomains: epigenetic readers of lysine acetylation P. Filippakopoulos, Stefan Knapp · Nature Reviews Drug Discovery Review	22 Apr 2014	1,267
7	Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection Shuo Feng et al. · Nature Medicine Open access	29 Sep 2021	1,247
8	Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey et al. · The Lancet Open access766 authors	21 Feb 2021	1,213
9	Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera Daming Zhou et al. · Cell Open access	23 Feb 2021	1,157
10	Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial Michele D. Tameris, Mark Hatherill, Bernard Landry et al. · The Lancet Open access	4 Feb 2013	1,060
11	SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Wanwisa Dejnirattisai et al. · Cell Open access466 authors	3 Jan 2022	1,027
12	Dectin-1 Is A Major β-Glucan Receptor On Macrophages Gordon D. Brown, Philip R. Taylor, Delyth M. Reid et al. · The Journal of Experimental Medicine Open access	29 Jul 2002	1,018
13	ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques Neeltje van Doremalen et al. · Nature Open access	30 Jul 2020	992
14	Type I Interferons Potently Enhance Humoral Immunity and Can Promote Isotype Switching by Stimulating Dendritic Cells In Vivo Agnès Le Bon, Giovanna Schiavoni, Giuseppina D’Agostino et al. · Immunity Open access	Apr 2001	974
15	Incorporating outlier detection and replacement into a non-parametric framework for movement and distortion correction of diffusion MR images Jesper Andersson, Mark S. Graham, Enikő Zsoldos et al. · NeuroImage Open access	6 Jul 2016	882
16	The lipocalin protein family: structural and sequence overview Darren R. Flower, Anthony C.T. North, Clare Sansom · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology	Oct 2000	877
17	The immune response during acute HIV-1 infection: clues for vaccine development Andrew James McMichael, Persephone Borrow, Georgia D. Tomaras et al. · Nature reviews. Immunology ReviewOpen access	11 Dec 2009	874
18	COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II Daniel H. Freeman, Bao Sheng Loe, Andrew T. Chadwick et al. · Psychological Medicine Open access	11 Dec 2020	816
19	Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon Agnès Le Bon, Nathalie Etchart, Cornelia Rossmann et al. · Nature Immunology	21 Sep 2003	812
20	Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections Andrea Stacey, Philip J. Norris, Qin Li et al. · Journal of Virology Open access	28 Jan 2009	766
21	Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum Chang Liu et al. · Cell Open access	17 Jun 2021	752
22	Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial Alasdair P S Munro et al. · The Lancet Open access308 authors	Dec 2021	699
23	What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 Susanne H. C. Hodgson, Kushal Mansatta, Garry Mallett et al. · The Lancet Infectious Diseases Open access	27 Oct 2020	673
24	Antibody evasion by the P.1 strain of SARS-CoV-2 Wanwisa Dejnirattisai et al. · Cell Open access	30 Mar 2021	661
25	The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection Nilu P Goonetilleke et al. · The Journal of Experimental Medicine Open access	Jun 2009	655
26	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial Katherine R. W. Emary et al. · The Lancet Open access	30 Mar 2021	652
27	The β-Glucan Receptor, Dectin-1, Is Predominantly Expressed on the Surface of Cells of the Monocyte/Macrophage and Neutrophil Lineages Philip R. Taylor, Gordon D. Brown, Delyth M. Reid et al. · The Journal of Immunology Open access	Oct 2002	651
28	T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial Katie Ewer et al. · Nature Medicine Open access284 authors	17 Dec 2020	646
29	The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery Joseph Alsousou, Mark S. Thompson, P A Hulley et al. · Journal of Bone and Joint Surgery - British Volume Open access	Aug 2009	600
30	Links between innate and adaptive immunity via type I interferon Agnès Le Bon, David F. Tough · Current Opinion in Immunology Review	Aug 2002	588
31	Viral infection switches non-plasmacytoid dendritic cells into high interferon producers Sandra S. Diebold, María Montoya, Hermann Unger et al. · Nature	22 Jun 2003	580
32	Major findings and recent advances in virus–like particle (VLP)-based vaccines Mona Omar Mohsen, Lisha Zha, Gustavo Cabral‐Miranda et al. · Seminars in Immunology	5 Sep 2017	571
33	Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial Xinxue Liu et al. · The Lancet Open access	6 Aug 2021	552
34	Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis Thirusha Lane et al. · Circulation Open access	21 May 2019	542
35	Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera Piyada Supasa et al. · Cell Open access	18 Feb 2021	529
36	Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo Milica Vukmanovic‐Stejic, Yan Zhang, Joanne E. Cook et al. · Journal of Clinical Investigation Open access	Sep 2006	491
37	Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines Andrew John Pollard, Kirsten P. Perrett, Peter C. L. Beverley · Nature reviews. Immunology Review	13 Feb 2009	487
38	Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac Disease Jason A. Tye–Din, Jessica A. Stewart, James A. Dromey et al. · Science Translational Medicine	21 Jul 2010	476
39	Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial Mehreen S. Datoo et al. · The Lancet Open access	May 2021	473
40	Initial T cell frequency dictates memory CD8+ T cell lineage commitment Amanda Lee Marzo, Kimberly D. Klonowski, Agnès Le Bon et al. · Nature Immunology Open access	17 Jul 2005	468
41	Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines Queenie Fernandes, Varghese Philipose Inchakalody, Maysaloun Merhi et al. · Annals of Medicine Open access	8 Feb 2022	462
42	IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation Fabrizio Mattei, Giovanna Schiavoni, Filippo Belardelli et al. · The Journal of Immunology Open access	Aug 2001	458
43	Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs Arun T. Kamath, Sandrine Henri, Frank L. Battye et al. · Blood	Sep 2002	455
44	On Iron Metabolism and Its Regulation Anne‐Cathrine S. Vogt, Tasneem Arsiwala, Mona Omar Mohsen et al. · International Journal of Molecular Sciences Open access	27 Apr 2021	453
45	Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond Wesley C. Van Voorhis et al. · PLoS Pathogens Open access187 authors	28 Jul 2016	452
46	Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial Munro, APS et al. · Sussex Research Online (University of Sussex) Open access	2 Dec 2021	445
47	Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank Louise V. Wain et al. · The Lancet Respiratory Medicine Open access	28 Sep 2015	441
48	Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization Karl D. Brune, Darren B. Leneghan, Iona J. Brian et al. · Scientific Reports Open access	19 Jan 2016	440
49	Towards a comprehensive framework for movement and distortion correction of diffusion MR images: Within volume movement Jesper Andersson, Mark S. Graham, Ivana Drobnjak et al. · NeuroImage Open access	8 Mar 2017	436
50	Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage Claire Dunn, Maurizia Rossana Brunetto, Gary M. Reynolds et al. · The Journal of Experimental Medicine Open access	12 Mar 2007	425

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.